Latest Health News
WHO warns of deadly escalation of attacks on health care in Sudan
WHO reports 201 verified attacks since April 2023, causing 1,858 deaths and 490 injuries and warns 2025 attacks are deadlier and more widespread, disrupting lifesaving services and endangering health workers and humanitarian operations. WHO highlights recent hospital strikes and mass casualties, including attacks that killed over 460 patients and the detention of dozens of health workers
.
Brazil validated for elimination of mother‑to‑child transmission of HIV
PAHO congratulates Brazil for being validated for eliminating mother‑to‑child transmission (EMTCT) of HIV, becoming the largest country to reach EMTCT and expanding subnational certifications including hepatitis B and HTLV. PAHO credits universal antiretroviral access and strengthened prevention strategies through Brazil’s Unified Health System for the achievement
.
WHO closes Global Summit on Traditional Medicine with integration commitments
WHO’s Second Global Summit on Traditional Medicine in New Delhi concluded with commitments to integrate safe, evidence‑informed traditional medicine into health systems and to launch a Global Traditional Medicine Centre and supporting strategy for 2025–2034. The summit brought ministers, scientists and Indigenous leaders from 100+ countries to prioritize research, regulation and system integration
.
GSK agrees with U.S. government to lower drug prices for respiratory medicines
GSK announced a voluntary agreement with the U.S. Administration to reduce prescription costs and expand access to respiratory medicines for millions of Americans, covering treatments for asthma and COPD. The company framed the deal as responding to U.S. policy requests while noting forward‑looking uncertainties
.
Mayo Clinic lists top research breakthroughs of 2025, including virtual clinical trials
Mayo Clinic highlighted major 2025 research advances such as AI‑driven 'virtual clinical trials' to predict heart failure drug success, regenerative lung therapies, and personalized neuromodulation for epilepsy. The announcement emphasizes initiatives (Precure, Genesis, BIONIC) to accelerate prediction, prevention and novel therapies
.
WHO and global review urge translating COVID lessons into stronger preparedness
A joint review stresses lessons from COVID‑19—solidarity, equity, science, and sustained preparedness—and urges countries to finalize WHO pandemic accord annexes on pathogen access and benefit sharing. WHO highlights investments like the Pandemic Fund and calls for stronger primary care, early detection and equitable access to counter future pandemics
.
Researchers report immune rejuvenation in aged mice using liver‑targeted mRNA nanoparticles
MIT and Broad Institute teams used liver‑targeted mRNA nanoparticles delivering thymic factors (DLL1, FLT3, IL‑7) to restore T cell diversity and improve vaccine responses in 18‑month‑old mice, suggesting a potential path for immune aging interventions though still preclinical.
Gates Institute and partners advance gene, cell therapies and Alzheimer vaccine manufacturing
The Gates Institute highlighted 2025 milestones including one‑time gene therapy for diabetic retinopathy, expanded CAR T trials, and an Alzheimer’s vaccine manufactured at the Gates Biomanufacturing Facility moving toward clinical testing. These programs aim to translate early discoveries into clinical options across blindness, cancer and neurodegeneration
.
Public health experts warn of rising winter respiratory virus activity (flu, COVID, RSV, measles)
Johns Hopkins public health analysis reports climbing respiratory virus rates in the U.S. ahead of winter 2025–26, noting increasing circulation of influenza, COVID‑19, RSV and localized measles outbreaks and urging preparedness measures. The analysis emphasizes surveillance, vaccination and primary care capacity to manage concurrent waves
.
CRISPR and gene‑editing advancements continue to shape 2025 translational pipeline
CRISPR Medicine News summarizes 2025 trends including expanded CRISPR applications beyond DNA editing, new biosensing chips for point‑of‑care testing, and ongoing clinical and regulatory developments across gene and cell therapies. The coverage highlights rapid translation but notes challenges in delivery, safety and equitable access
.
WHO warns of health risks from poorly managed waste and emerging influenza strain
WHO issued alerts in December 2025 on risks from mismanaged waste to public health and urged vaccination as a new influenza strain emerged, reinforcing preventive actions and waste management reforms to protect communities.
Research highlights: immune mechanisms, cancer biology, and organ‑repair therapies
Institutes including LucidQuest, Van Andel and Huntsman summarized 2025 scientific advances—EPO’s role in immune tolerance, liver‑delivered factors rejuvenating immunity, new cancer immunotherapy targets, and promising regenerative approaches for lung and kidney disease—pointing to translational opportunities in immunology and organ repair.